Volume 89 Issue 41 | p. 23 | Concentrates
Issue Date: October 10, 2011

ScinoPharm Lists On Taiwan Stock Market

Department: Business
Keywords: contract manufacturing, IPO, China
[+]Enlarge
ScinoPharm cofounders Hardy W. Chan and Jo Shen at the 2009 groundbreaking for their Chinese plant.
Credit: Jean-François Tremblay/C&EN
Hardy W. Chan (left) and Jo Shen at the 2009 groundbreaking of ScinoPharm’s plant in Changshu, China. It will make active pharmaceutical ingredients.
 
ScinoPharm cofounders Hardy W. Chan and Jo Shen at the 2009 groundbreaking for their Chinese plant.
Credit: Jean-François Tremblay/C&EN

ScinoPharm, Taiwan’s largest producer of active pharmaceutical ingredients (APIs), has listed on the Taiwan Stock Exchange in a stock offering that values the company at $950 million. ScinoPharm raised $32 million from the listing to finance its expansion. More than half of the company is owned by the Taiwanese conglomerate Uni-President. ScinoPharm, which has headquarters in southern Taiwan, produces most of the APIs that the island exports. The company is completing construction of another facility in Changshu, Jiangsu province, China.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment